SD 1 cry-20210528corresp.htm FORM SD Form SD



 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 

FORM SD



Specialized Disclosure Report
 

_______________________
 

CRYOLIFE, INC.

(Exact name of registrant as specified in its charter)
 

_________________________

 



 

 

Florida

1-13165

59-2417093

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer

Identification No.)

 

1655 Roberts Boulevard, N.W., Kennesaw, Georgia  30144
(Address of principal executive office) (zip code)
 

Registrant's telephone number, including area code: (770) 419-3355
 

_____________________________________________________________

 

(Former name or former address, if changed since last report)
 

_______________________________________________________________

 

Check the appropriate box to indicate the rule pursuant to which this form is being filed, and provide the period to which the information in this form applies:



☒Rule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1 to December 31, 2020





 

 

 

 







Section 1 -- Conflict Minerals Disclosure

Item 1.01  Conflict Minerals Disclosure and Report

This Form SD of CryoLife, Inc. (the “Company”) is filed pursuant to Rule 13p-1 promulgated under the Securities Exchange Act of 1934, as amended, for the reporting period January 1, 2020 to December 31, 2020.    

A copy of the Company’s Conflict Minerals Report is provided as Exhibit 1.01. This Form SD and the Conflict Minerals Report is publicly available on the Company’s website at http://investors.cryolife.com.

Item 1.02  Exhibit

As specified in Section 2, Item 2.01 of this Form SD, the Company is hereby filing its Conflict Minerals Report as Exhibit 1.01 to this Form SD.

Section 2 -- Exhibits

Item 2.01 Exhibits



 

Exhibit No.

Description

1.01

Conflict Minerals Report as required by Item 1.01 and 1.02 of this Form



2

 

 

 







SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, CryoLife, Inc. has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CRYOLIFE, INC.

 

 

 

 

Date: May 28, 2021

 

 

 

By:

 

/s/ Jean F. Holloway

 

 

 

 

Name:

 

Jean F. Holloway

 

 

 

 

Title:

 

Senior Vice President, General Counsel,

 

 

 

 

 

 

Chief Compliance Officer, and

 

 

 

 

 

 

Corporate Secretary



 

3